Close-up of shredded document
Biotech

Genentech scraps $2B cell therapy pact with Adaptive

The Jan. 2019 pact with Adaptive Biotech was meant to see Genentech develop personalized cancer therapies based on Adaptive’s T-cell receptor tech.
Darren Incorvaia Aug 18, 2025 2:40pm
Investigational Rosnilimab Emerges as a Novel Differentiated Treatment Option for Rheumatoid Arthritis

Investigational Rosnilimab Emerges as a Novel

Aug 18, 2025 8:00am
white hawk bird flying

Merck KGaA swoops to $2B neurological disease pact with Skyhawk

Aug 18, 2025 9:49am
federal website NIH

NIH chief orders immediate research review, threatens cuts

Aug 15, 2025 3:53pm
delay FDA delay

Another biotech hit with FDA delay for ALS asset

Aug 18, 2025 11:01am
sickle cell disease

Pfizer's SCD drug fails ph. 3 study in latest blow to GBT legacy

Aug 18, 2025 7:31am
More News

New blood pressure guidelines include renal denervation

Aug 18, 2025 3:15pm

Private equity firm acquires site network Headlands Research

Aug 18, 2025 1:53pm

Stealth Bio submits rare disease application for the third time

Aug 18, 2025 11:08am

Baxter’s infusion pump safety issues grow in scope

Aug 18, 2025 11:00am